Avior Wealth Management LLC Increases Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

Avior Wealth Management LLC raised its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 128.7% during the 4th quarter, Holdings Channel reports. The firm owned 7,386 shares of the financial services provider’s stock after purchasing an additional 4,157 shares during the quarter. Avior Wealth Management LLC’s holdings in iShares Biotechnology ETF were worth $977,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of IBB. Darwin Wealth Management LLC purchased a new stake in shares of iShares Biotechnology ETF in the third quarter valued at about $29,000. Highline Wealth Partners LLC purchased a new stake in shares of iShares Biotechnology ETF in the third quarter valued at about $30,000. Ashton Thomas Securities LLC purchased a new stake in shares of iShares Biotechnology ETF in the third quarter valued at about $36,000. Modus Advisors LLC purchased a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at about $41,000. Finally, Voisard Asset Management Group Inc. purchased a new position in shares of iShares Biotechnology ETF during the third quarter valued at approximately $59,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of IBB opened at $137.30 on Friday. The company’s 50 day simple moving average is $136.04 and its 200 day simple moving average is $141.78. iShares Biotechnology ETF has a 1 year low of $123.60 and a 1 year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were paid a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.